Gary Ingenito - 20 Nov 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
20 Nov 2024
Net transactions value
-$653,182
Form type
4
Filing time
22 Nov 2024, 17:00:09 UTC
Previous filing
13 Aug 2024
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $152,380 +38,000 +74% $4.01 89,391 20 Nov 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $805,562 -38,000 -43% $21.20 51,391 20 Nov 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -38,000 -4% $0.000000 912,575 20 Nov 2024 Common Stock 38,000 $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $21.18 to $21.27 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.